Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas.
Why is it that primary melanomas which are less than 0.76 mm in thickness are almost always curable by surgery whereas thicker lesions are associated with a worse prognosis? Put in another way, why is it that such small increases in tumor thickness beyond 0.76 mm are often associated with the eventual formation of distant metastases and death? Part of the answer lies in the dramatic qualitative changes which can accompany small increases in the size of primary human melanomas. Thus, primary melanomas less than 0.76 mm in thickness usually contain very low proportions of metastatically competent tumor cells, whereas slightly thicker lesions can contain very high proportions of such cells, resulting from a selective growth advantage of the latter in the dermal mesenchyme. This overgrowth process is akin to a 'malignant eclipse' phenomenon (by analogy with a solar eclipse). We have been studying the causes of the malignant eclipse in melanoma, for which there are at least four possibilities: 1) an increase in autocrine, mitogenic growth factors by melanoma cells; 2) a decreased rate of apoptosis in the same population; 3) an acquired resistance to paracrine growth inhibitory factors; and 4) an increased ability to induce an angiogenic response. Evidence exists for all four possibilities. Our experimental approach to studying this problem has relied heavily on the use of cell lines obtained from early stage radial growth phase or vertical growth phase lesions which have a clinical-like inability to grow progressively in nude mice, and variants obtained from such lines which are aggressively tumorigenic. Using such paired lines, and other experimental systems, we have obtained evidence that shows early stage melanoma cell lines may be deficient in inducing angiogenesis, are highly sensitive to the growth inhibitory effects of a plethora of cytokines, including transforming growth factor beta, interleukin-6, and oncostatin M, and are more sensitive to undergoing spontaneous apoptosis in several conditions including when growth in anchor-age-independent, 3-dimensional tissue culture. How this information may impact tumor prognosis and the design and effects of new strategies to treat melanoma, especially antiangiogenesis strategies, is discussed.
Kerbel
R S
RS
Division of Cancer Biology Research, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
Kobayashi
H
H
Graham
C H
CH
Lu
C
C
D000818:Animals; D017209:Apoptosis; D006801:Humans; D008545:Melanoma / Q000098:blood supply / Q000473:pathology*; D051379:Mice; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000209:etiology; D012878:Skin Neoplasms / Q000098:blood supply / Q000473:pathology*; D014407:Tumor Cells, Cultured